Literature DB >> 20403087

Hippocampal microinfusion of oxytocin attenuates the behavioural response to stress by means of dynamic interplay with the glucocorticoid-catecholamine responses.

H Cohen1, Z Kaplan, N Kozlovsky, Y Gidron, M A Matar, J Zohar.   

Abstract

The neurohypophysial hormone oxytocin acts as a central nervous system neurotransmitter/neuromodulator. We evaluated the effects of oxytocin on behavioural responses to stress, as well as associated biophysiological responses, in a controlled, prospective animal model. The long-term effects of exogenous oxytocin microinjected to the hippocampus of male rats were assessed. Animals were exposed to predator scent stress and treated 1 h or 7 days later with oxytocin or vehicle. Behaviours were assessed with the elevated plus-maze and acoustic startle response tests, 7 days after microinjection and freezing behaviour upon exposure to a trauma-related cue on day 8. These data served for classification into behavioural response groups. Trauma cue response, circulating corticosterone and oxytocin, hippocampal expression of glucocorticoid and mineralocorticoid receptors, and oxytocin receptor mRNA levels were assessed. The interplay between oxytocin, corticosterone and norepinephrine was assessed. Microinfusion of oxytocin both immediately after predator scent stress exposure or 7 days later, after exposure to trauma cue significantly reduced the prevalence rates of extreme responders and reduced trauma cue freezing responses. Post-exposure treatment with oxytocin significantly corrected the corticosterone stress response, decreased glucocorticoid receptor expression and increased mineralocorticoid receptor expression in the hippocampus compared to vehicle treatment. High-dose corticosterone administration together with norepinephrine caused release of plasma oxytocin and hippocampal oxytocin receptor. Oxytocin is actively involved in the neurobiological response to predator scent stress processes and thus warrants further study as a potential therapeutic avenue for the treatment of anxiety-related disorders.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20403087     DOI: 10.1111/j.1365-2826.2010.02003.x

Source DB:  PubMed          Journal:  J Neuroendocrinol        ISSN: 0953-8194            Impact factor:   3.627


  30 in total

Review 1.  Prevention of Trauma and Stressor-Related Disorders: A Review.

Authors:  Jonathon R Howlett; Murray B Stein
Journal:  Neuropsychopharmacology       Date:  2015-08-28       Impact factor: 7.853

2.  A predator-based psychosocial stress animal model of PTSD in females: Influence of estrous phase and ovarian hormones.

Authors:  Phillip R Zoladz; Paul A D'Alessio; Sarah L Seeley; Charis D Kasler; Cassandra S Goodman; Kasey E Mucher; Alanis S Allison; Ian F Smith; Jordan L Dodson; Thorne S Stoops; Boyd R Rorabaugh
Journal:  Horm Behav       Date:  2019-08-21       Impact factor: 3.587

Review 3.  Anxiety, Depression, and the Microbiome: A Role for Gut Peptides.

Authors:  Gilliard Lach; Harriet Schellekens; Timothy G Dinan; John F Cryan
Journal:  Neurotherapeutics       Date:  2018-01       Impact factor: 7.620

4.  Reproductive Stage and Modulation of Stress-Induced Tau Phosphorylation in Female Rats.

Authors:  Danielle Steinmetz; Eugenia Ramos; Shannon N Campbell; Teresa Morales; Robert A Rissman
Journal:  J Neuroendocrinol       Date:  2015-11       Impact factor: 3.627

5.  Oxytocin in schizophrenia: a review of evidence for its therapeutic effects.

Authors:  Kai Macdonald; David Feifel
Journal:  Acta Neuropsychiatr       Date:  2011-12-19       Impact factor: 3.403

6.  Microbial lysate upregulates host oxytocin.

Authors:  Bernard J Varian; Theofilos Poutahidis; Brett T DiBenedictis; Tatiana Levkovich; Yassin Ibrahim; Eliska Didyk; Lana Shikhman; Harry K Cheung; Alexandros Hardas; Catherine E Ricciardi; Kumaran Kolandaivelu; Alexa H Veenema; Eric J Alm; Susan E Erdman
Journal:  Brain Behav Immun       Date:  2016-11-05       Impact factor: 7.217

7.  Effects of intranasal oxytocin on amygdala reactivity to emotional faces in recently trauma-exposed individuals.

Authors:  Jessie L Frijling; Mirjam van Zuiden; Saskia B J Koch; Laura Nawijn; Dick J Veltman; Miranda Olff
Journal:  Soc Cogn Affect Neurosci       Date:  2015-09-17       Impact factor: 3.436

8.  Impact of Low Dose Oral Exposure to Bisphenol A (BPA) on the Neonatal Rat Hypothalamic and Hippocampal Transcriptome: A CLARITY-BPA Consortium Study.

Authors:  Sheryl E Arambula; Scott M Belcher; Antonio Planchart; Stephen D Turner; Heather B Patisaul
Journal:  Endocrinology       Date:  2016-08-29       Impact factor: 4.736

9.  Effects of oxytocin on working memory and executive control system connectivity in posttraumatic stress disorder.

Authors:  Julianne C Flanagan; Anne Hand; Amber M Jarnecke; Megan M Moran-Santa Maria; Kathleen T Brady; Jane E Joseph
Journal:  Exp Clin Psychopharmacol       Date:  2018-08       Impact factor: 3.157

Review 10.  Brain circuit dysfunction in a distinct subset of chronic psychotic patients.

Authors:  Morris B Goldman
Journal:  Schizophr Res       Date:  2014-07-01       Impact factor: 4.939

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.